Quantcast

Latest Clinical trial Stories

2014-09-11 08:27:36

Life sciences service providers leverage PAREXEL's eClinical solutions to simplify drug development for customers through technology partnership initiative BOSTON, Sept. 11, 2014 /PRNewswire/ -- PAREXEL International (NASDAQ: PRXL), a leading global biopharmaceutical services organization, today announced that clinical technology companies CRF Health and Clinical Ink have joined its Perceptive® Partner Program. Through the program, technology, consulting, reseller and training companies, as...

2014-09-11 04:20:52

DALLAS, September 11, 2014 /PRNewswire/ -- MarketReportsOnline.com adds Latest Chinese Guidebook for Application and Approval of Imported Medical Device Registration: From Regulations to Practices (2014 Edition) research report of 194 pages to its store. This research not only provides a comprehensive and thorough knowledge of the latest Chinese regulations for imported medical device registration but also introduces the practical operation on how to comply with the Chinese...

2014-09-10 16:26:51

Approval based on improved overall survival, delayed time to radiographic progression and an overall positive benefit-risk profile TOKYO and SAN FRANCISCO, Sept. 10, 2014 /PRNewswire/ -- Astellas Pharma Inc. (Tokyo: 4503) and Medivation, Inc. (Nasdaq: MDVN) announced today that the U.S. Food and Drug Administration (FDA) approved a new indication for the use of XTANDI(®) (enzalutamide) capsules to treat patients with metastatic castration-resistant prostate cancer (CRPC). This new approved...

2014-09-10 12:29:18

LONDON, ON, Sept. 10, 2014 /CNW/ - "Clinical testing has been one of the biggest barriers to developing new imaging technology for clinical application", says Alvira Macanovic, IP, Regulatory and Clinical Affairs Manager at the Centre for Imaging Technology Commercialization (CIMTEC). "This very important CIMTEC initiative will make it easier for researchers and small and medium-sized companies to achieve a range of goals such as generating clinical data to support pre-market...

2014-09-10 12:28:22

WASHINGTON, Sept. 10, 2014 /PRNewswire-USNewswire/ -- The following is a statement on behalf of RetireSafe: Dear Member of Congress; We write to you today to bring to your attention a critical safety issue that could affect all Americans, but especially those older Americans who rely on relatively new medicines called "biologics". RetireSafe, a 400,000-supporter strong nationwide advocacy organization for seniors, works hard to give a voice to retired Americans and those who hope to retire....

2014-09-10 08:30:43

New addition expands WCG's New England presence and increases its expertise in all phases of clinical research PRINCETON, N.J., Sept. 10, 2014 /PRNewswire/ -- WIRB-Copernicus Group (WCG), the world's largest provider of regulatory and ethical review services for clinical research, announced today that New England Independent Review Board (IRB) has joined the group of companies. Based near Boston, MA, New England IRB expands WCG's presence in the important New England clinical...

2014-09-09 23:09:41

Quorum Review IRB, the industry leader in central IRB services, announces a new streamlined service for Retrospective Chart Reviews. Seattle, WA (PRWEB) September 09, 2014 Quorum Review IRB, the industry leader in central IRB services, announces a new streamlined service for Retrospective Chart Reviews. The service was piloted earlier this year with several clients and was rolled out to all Quorum’s clients with the new Expeditable Research Review offering. The Retrospective Chart...

2014-09-09 23:02:43

Advanced new studies seek to uncover therapeutic interventions for FSHD Lexington, MASS (PRWEB) September 09, 2014 The FSH Society, a Massachusetts based non-profit that is a world leader in combating facioscapulohumeral dystrophy (FSHD), announced that it has awarded three grants totaling $193,150 to new research projects. Through these studies, the FSH Society’s fellowship and grant program aims to gain insights and achieve significant milestones into the research of FSHD, one of the...

2014-09-09 16:26:44

PLEASANTON, Calif., Sept. 9, 2014 /PRNewswire/ -- Thoratec Corporation (NASDAQ: THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, announced today that it has begun to enroll patients in the HeartMate III(TM) U.S. clinical trial. "We are excited to continue our recent pipeline progress with the start of the U.S. clinical trial for HeartMate III," said Gary F. Burbach, President and Chief Executive Officer....

2014-09-09 12:28:20

HealthiVibe bridges the gap between clinical trials and patient involvement. The company will present at Disruptive Innovations, September 10 & 12 in Boston. ARLINGTON, Va., Sept. 9, 2014 /PRNewswire/ -- HealthiVibe, LLC, a newly formed company, aims to pioneer a new model in which the patient voice becomes central to clinical trial development. Founded by Abbe Steel, a 23-year veteran of the pharmaceutical industry, HealthiVibe uses a novel approach to gathering patient feedback....


Word of the Day
omadhaun
  • A fool; a simpleton: a term of abuse common in Ireland and to a less extent in the Gaelic-speaking parts of Scotland.
This word is partly Irish in origin.